Connect with us

News

Trudeau offers sombre Christmas message but says 500,000 vaccine doses are coming early in the new year – CBC.ca

Published

 on


While Prime Minister Justin Trudeau acknowledged today that Christmas won’t be the same this year, with wide swaths of the country under COVID-related lockdowns, he said there’s reason for optimism in 2021 now that hundreds of thousands of vaccine doses are expected to arrive early in the new year.

Speaking to reporters outside Rideau Cottage in Ottawa, Trudeau said the government got word today that Pfizer will be shipping 125,000 vaccine doses per week in January 2021 for a total of 500,000 shots — primarily destined for the arms of front line health care workers and long-term care home residents. Pfizer has committed already to delivering 249,000 doses to Canada in December.

All told, roughly 375,000 Canadians are expected to be vaccinated with the two-dose Pfizer shot by the end of January.

Canada is also anticipating the delivery this month of 168,000 doses of the Moderna vaccine, enough for about 84,000 people. The Moderna product is still waiting on Health Canada’s regulatory approval.

“This is the largest immunization campaign our country has ever seen, and I know we have the right plan and the expertise we need,” Trudeau said. “But remember, a vaccine in a week or in a month won’t help you if you get COVID-19 today.”

WATCH: Prime Minister Trudeau offers update on vaccine delivery

Prime Minister Justin Trudeau spoke with reporters outside Rideau Cottage on Friday. 1:57

Trudeau urged Canadians to continue to follow public health guidelines over the holidays. While the vaccine news is promising, he said, Canadians should resist complacency.

“Our fight against this virus is not over, even as we’re preparing to say goodbye — and good riddance — to 2020. It may be the holiday season, but we have to be more careful than ever,” Trudeau said.

Asked about the prospect of getting even more Pfizer doses, Public Services and Procurement Minister Anita Anand said today she’s in constant communication with the company to discuss the possibility of “accelerated timelines” and to “ensure Canada has the earliest possible access to Pfizer doses.”

Canada is still on track to take delivery of 4 million doses of the Pfizer vaccine in the first three months of 2021, she said.

Dr. Scott Gottlieb, the former the head of the U.S. Food and Drug Administration and a current Pfizer board member, said this week that because the U.S. passed on ordering 100 million more doses of the vaccine, the company’s Kalamazoo, Mich., plant could send that product to other countries in the second quarter of 2021.

Watch: Trudeau questioned about vaccine deliveries, impact on Christmas.:

Prime Minister Justin Trudeau spoke with the CBC’s Tom Parry on Friday. 2:19

Canada’s chief public health officer, Dr. Theresa Tam, said today’s announcement that Canada will receive a specific number of Pfizer doses in January may give the provinces leeway to accelerate their vaccination campaigns.

While all provinces have started delivering shots, most have stockpiled the second dose of the two-dose regime to ensure they have enough supply on hand.

If a steady supply of vaccines is expected, Tam said, some provinces may opt to just vaccinate as many people as possible without keeping a reserve.

“It’s great to hear this schedule,” Tam said. “If you know there’s 125,000 coming per week in January, that makes planning for that second dose much easier in terms of not necessarily having to hold back the initial ones … so I think those details are to be worked out on the ground.”

Pfizer has stipulated that the second shot should be administered 21 days after the first to ensure the 94 per cent effectiveness rate documented in the clinical trials

U.S. vaccination campaign pulling ahead of Canada

The U.S. is expected to vaccinate many more people than Canada in the coming weeks.

Gen. Gustave Perna is the military general leading Operation Warp Speed, the U.S. mission to develop and distribute a vaccine. He said Pfizer already has shipped 2.9 million doses to the United States, with millions more to follow by month’s end.

Some U.S. governors, however, are reporting that their allocations of the vaccine are less than what they expected.

The U.S. also has secured 100 million doses of the promising Moderna product for the first three months of 2021 alone. Canada expects to receive about 2 million Moderna doses between January and March.

Operation Warp Speed largely bankrolled the vaccine’s development, the clinical trial process and the large-scale manufacturing operations, spending $4.1 billion so far to support Moderna.

Dr. Moncef Slaoui, the chief science adviser to the U.S. vaccine operation, has said every American who wants a vaccine will get one by June.

The Public Health Agency of Canada told CBC News Tuesday that it expects to have enough vaccine doses on hand to vaccinate every Canadian by the end of September, 2021.

Asked what he would do to close the Canada-U.S. vaccine gap, Trudeau said the federal government has secured one of the broadest portfolios of promising vaccine candidates in the world.

“The Americans have a health care system that will have challenges and will have successes. We have our own process. We’re focused on our own process to make sure that as many Canadians as possible get vaccinated, as quickly as possible, with vaccines that are safe and effective and approved by Health Canada,” he said.

Watch: Trudeau is asked why many Canadians aren’t listening to pandemic messaging.:

Prime Minister Justin Trudeau spoke with reporters at Rideau Cottage on Friday. 1:58

Let’s block ads! (Why?)



Source link

Continue Reading

News

PM warns Canadians to expect more travel restrictions soon – CTV News

Published

 on


TORONTO —
Prime Minister Justin Trudeau is warning Canadians to expect more travel restrictions in the near future.

At his briefing Tuesday, Trudeau reiterated federal public health guidance to avoid all non-essential travel, both abroad and in between provinces.

Trudeau said in French that the constantly evolving news of COVID-19 variants from other countries has spurred the government to look at improving the measures already implemented – and that an announcement would come very soon.

The prime minister also reiterated his previous statements on upcoming travel, telling Canadians to cancel any plans they may have booked, and that while the number of cases linked to traveling abroad are low, “one case is too many.”

Trudeau said the “bad choices of a few” should not be allowed to put others at risk.

Currently, the land border between Canada and the U.S. remains closed to travellers, while international travellers flying into the country must show a negative COVID-19 test 72 hours before their departure flight. They then must quarantine for 14 days upon arrival.

Violations of any of these measures can result in charges under the Quarantine Act, with a maximum sentence of six months in jail or fines up to $75,000.

Last week, Quebec Premier Francois Legault called for Ottawa to implement an outright ban on non-essential travel – and as Trudeau said at his Tuesday briefing, “all options are on the table if necessary.”

The Public Health Agency of Canada has reported more than 200 flights, both international and domestic, that have confirmed COVID-19 cases, as well as one VIA Rail train trip.

Overall, travel outside Canada has been deemed the primary cause of 1.4 per cent of COVID-19 cases in Canada since the start of the pandemic, with contact with a traveller accounting for another one per cent of infections.

Let’s block ads! (Why?)



Source link

Continue Reading

News

Made-in-Canada coronavirus vaccine starts human clinical trials – CBC.ca

Published

 on


A made-in-Canada vaccine to protect against COVID-19 began human clinical trials Tuesday in Toronto, says the biotechnology company that developed the vaccine.

Toronto-based Providence Therapeutics said three shots will be given to 60 adult volunteers at a clinical trial site in Toronto in the first phase of the trial on Tuesday. 

Fifteen of those volunteers will receive a placebo, and 45 will get the vaccine, called PTX-COVID19-B.

Brad Sorenson, the company’s CEO, said it’s the first time a vaccine designed and manufactured in Canada has begun clinical trials. The company has purchased a site in Calgary to mass produce the vaccine. 

Vaccines are designed to trigger an immune response in the body. Providence’s product is an mRNA vaccine and is similar to the Moderna coronavirus shot being given to people across Canada.

Quebec-based pharmaceutical Medicago began clinical trials last July of its coronavirus vaccine that is based on another technology. Unlike Providence, a large portion of Medicago’s vaccine doses will be manufactured outside the country, in North Carolina.

A vial is shown in this handout image provided by Providence Therapeutics. The company says it is the first fully made-in-Canada coronavirus vaccine to reach clinical trials in this country. (Providence Therapeutics/The Canadian Press)

Medicago’s vaccine is currently in Phase 3 clinical trials — the last stage before it can apply for approval from Health Canada and other regulators to market the product. 

Sorenson said Providence designed and built its vaccine last March.

“We reached out to the Canadian government in April and said, ‘Hey, you’ve heard of Moderna. We’re doing the exact same thing,'” Sorenson said in an interview.

“We went from concept into the clinic in under a year without the same level of support as our peers had.”

Purchased Calgary site

The federal government provided financial sponsorship and support for the early phase clinical trial through the National Research Council of Canada’s Industrial Research Assistance Program. 

Currently, Canada lacks the capacity to manufacture the millions of doses of coronavirus vaccines needed to immunize people outside of a clinical trial setting. It’s why the federal government struck deals with Pfizer and Moderna — both manufactured abroad — to obtain the vaccines being rolled out across Canada.

While the company was developing the vaccine in pre-clinical studies, Sorenson said it also started to build the infrastructure to manufacture the vaccine in Canada as well.

A typical vaccination station is seen at the COVID-19 vaccination clinic at the Health Sciences Centre in Winnipeg on Dec. 14. Currently, Canada lacks the capacity to manufacture the millions of doses of coronavirus vaccines needed to immunize people outside of a clinical trial setting. (John Woods/The Canadian Press)

The company purchased a 20,000-square-foot facility in Calgary that includes 12,000 square feet of lab space to mass produce the vaccine. The facility will be up and running in two months, Sorensen said. 

Pending regulatory approval, a larger Phase 2 trial with adults over 65, youths under 18 and pregnant people could start in May, Sorenson said.

Initial focus was cancer research

If the vaccine proves safe and effective in clinical trials and Health Canada approves it, the goal is to have it ready for the global market by January 2022.

Sorenson founded Providence Therapeutics in 2013 to focus on cancer vaccines.

Several scientists contributed to the pre-clinical research on Providence’s vaccine, including those at the lab of Dr. Mario Ostrowski, a scientist at the Keenan Research Centre for Biomedical Science and an infectious disease clinician at St. Michael’s Hospital, Dr. Anne-Claude Gingras at Mt. Sinai Hospital, Dr. Samira Mubareka and Dr. Rob Kozak at Sunnybrook Research Institute, as well as Dr. Michael Pollanen, Ontario’s chief forensic pathologist.

In August, Ostrowski, whose laboratory performed the animal trials, said results were on par with tests of vaccines from Moderna and Pfizer-BioNTech at that stage.

Let’s block ads! (Why?)



Source link

Continue Reading

News

Coronavirus: What's happening in Canada and around the world on Tuesday – CBC.ca

Published

 on


The latest:

The European Union on Tuesday warned pharmaceutical giants that develop coronavirus vaccines to honour their contractual obligations after slow deliveries of shots from two companies hampered the bloc’s vaunted vaccine rollout in several nations.

The bloc already lashed out Monday at pharmaceutical company AstraZeneca, accusing it of failing to guarantee the delivery of coronavirus vaccines without a valid explanation. It also had expressed displeasure over vaccine delivery delays from Pfizer-BioNTech last week.

“Europe invested billions to help develop the world’s first COVID-19 vaccines. To create a truly global common good,” EU Commission President Ursula von der Leyen told the World Economic Forum’s virtual event in Switzerland. “And now, the companies must deliver. They must honour their obligations.”

The statement Tuesday highlighted the level of distrust that has grown between the 27-nation bloc and pharmaceutical companies over the past week.

On Monday, the EU threatened to impose strict export controls on all coronavirus vaccines produced in the bloc to make sure that companies honour their commitments to the EU.

A doctor adjusts his personal protective gear before entering a patient’s room at a COVID-19 intensive care unit at Klinikum Rechts der Isar hospital in Munich, southern Germany on Monday. (Lennart Preiss/AFP/Getty Images)

The EU said it provided €2.7 billion (more than $4.1 billion Cdn) to speed up vaccine research and production capacity and was determined to get some value for that money with hundreds of millions of vaccine shots according to a schedule the companies had committed to.

“Europe is determined to contribute to this global common good, but it also means business,” von der Leyen said Tuesday via video link.

Germany was firmly behind von der Leyen’s view. 

“With a complex process such as vaccine production, I can understand if there are production problems — but then it must affect everyone fairly and equally,” German Health Minister Jens Spahn told ZDF television. “This is not about EU first, it’s about Europe’s fair share.”

The EU, which has 450 million citizens and the economic and political clout of the world’s biggest trading bloc, is lagging badly behind countries like Israel and Britain in rolling out coronavirus vaccine shots for its health-care workers and most vulnerable people. That’s despite having over 400,000 confirmed virus deaths since the pandemic began.

The EU has committed to buying 300 million AstraZeneca doses with an option on 100 million extra shots. Late last week, the company said it was planning to reduce a first contingent of 80 million to 31 million.

The shortfall of planned deliveries of the AstraZeneca vaccine, which is expected to get medical approval by the bloc on Friday, combined with hiccups in the distribution of Pfizer-BioNTech shots is putting EU nations under heavy pressure. Pfizer says it was delaying deliveries to Europe and Canada while it upgrades its plant in Belgium to increase production capacity.

The European Medicines Agency is scheduled to review the Oxford-AstraZeneca coronavirus vaccine Friday and its approval is hotly anticipated. The AstraZeneca vaccine is already being used in Britain and has been approved for emergency use by half a dozen countries, including India, Pakistan, Argentina and Mexico.

The delays in getting vaccines will make it harder to meet early targets in the EU’s goal of vaccinating 70 per cent of its adults by late summer.

The EU has signed six vaccine contracts for more than two billion doses, but only the Pfizer-BioNTech and Moderna vaccines have been approved for use so far.

-From The Associated Press, last updated at 7:15 a.m. ET


What’s happening in Canada

WATCH | Inside two Toronto ICUs one year since Canada’s first COVID-19 case:

A look inside two Toronto hospital ICUs one year after Canada’s first case of COVID-19, and at the doctors and nurses both exhausted and determined to keep fighting. 4:28

As Parliament resumed Monday, Prime Minister Justin Trudeau faced a barrage of questions from MPs of all parties as they blasted the Liberal government for what they described as a botched approach to rolling out vaccines.

Both Trudeau and Procurement Minister Anita Anand repeated the government’s promise that by the end of September, all Canadians wishing to be vaccinated will have received their shots.

Trudeau has stressed that the delay that is currently hampering vaccination efforts is only temporary and that Canada is expected to receive four million doses of the Pfizer vaccine by the end of March. The prime minister noted that the country is still receiving shipments of the Moderna vaccine.

Earlier Monday, Deputy Prime Minister Chrystia Freeland said there is “tremendous pressure” on the global supply chain for vaccines that the government has tried to mitigate.

“We are working on this every single day, because we know how important vaccines are to Canadians, to first and foremost the lives of Canadians and also to our economy,” she told a news conference in Ottawa by video.

WATCH | New urgency for vaccinations in long-term care homes:

Faced with a COVID-19 vaccine shortage, Ontario says it will now vaccinate only long-term care residents and other seniors in at-risk retirement homes and care settings. 2:54

Despite the vaccine delay, some provinces continued to report encouraging drops in the number of new cases and hospitalizations. Ontario reported fewer than 2,000 cases on Monday, as well as fewer people in hospital. It was a similar story in Quebec, where hospitalizations dropped for a sixth straight day.

As of early Tuesday morning, Canada had reported 753,011 cases of COVID-19, with 62,444 cases considered active. A CBC News tally of deaths stood at 19,238.

In Alberta, health officials reported the province’s first case of a COVID-19 variant first seen in the United Kingdom that can’t be directly traced to international travel. Health Minister Tyler Shandro said that while it is one case, the variant has the potential to spread faster than the original novel coronavirus and could quickly overwhelm hospitals if not checked.

“There’s no question that this kind of exponential growth would push our health-care system to the brink,” Shandro told a virtual news conference Monday.

Here’s a look at what’s happening across Canada:

From The Canadian Press and CBC News, last updated at 6:45 a.m. ET 


 What’s happening around the world

As of early Tuesday morning, more than 99.7 million cases of COVID-19 had been reported worldwide, with more than 55.1 million of the cases considered recovered or resolved, according to a tracking tool maintained by Johns Hopkins University. The global death toll stood at more than 2.1 million.

In Europe, the U.K. is set to announce changes to its quarantine rules later Tuesday that could see anyone arriving in the country having to spend ten days in a hotel at their own expense. Vaccines minister Nadhim Zahawi said there will be an “announcement on this issue later on today,” but would not be drawn on what the changes would entail.

The British government has been reviewing its quarantine policies amid concerns over new variants of the coronavirus. Whether the changes will be universal and apply to everyone arriving, including British citizens, or just to those arriving from high-risk coronavirus countries, is unclear. Zahawi told Sky News that “as we vaccinate more of the adult population, if there are new variants like the South African or the Brazilian variants, we need to be very careful.”

Pedestrians walk past a sign pointing toward a COVID-19 testing centre in Walthamstow over the weekend in London. (Hollie Adams/Getty Images)

The U.K. has seen more than 3.6 million reported cases of COVID-19 since the pandemic began, according to Johns Hopkins University, with more than 98,700 deaths.

Chrystia Freeland, Canada’s deputy prime minister and finance minister, said Monday that Canada is considering additional international travel restrictions. Speaking on CBC’s Power & Politics, Freeland said she is, “very sympathetic to the view that, with the virus raging around the world, we need to be sure our borders are really, really secure.”

In Portugal, the health minister said authorities are considering asking other European Union countries for help amid a steep surge in COVID-19 cases. Portugal has had the world’s worst rate of new daily cases and deaths per 100,000 people for the past week, according to a tally by Johns Hopkins University.

Health Minister Marta Temido said sending patients to other EU countries is not uncommon in the bloc. But, she said, Portugal has the disadvantage of being geographically remote and hospitals across the continent are under pressure from the pandemic. She said the country may instead be asking for medical workers to be sent.

Portuguese hospitals are under severe strain, Temido told public broadcaster RTP. “We have beds available,” she said. “What we’re struggling with is finding staff.”

That request may be difficult to fulfil, because all countries in the 27-nation bloc are dealing with their own pandemic strains, made more difficult now because of the emergence of virus variants.

In the Asia-Pacific region, health authorities in Taiwan are quarantining 5,000 people while looking for the source of two new coronavirus cases linked to a hospital.

Indonesia’s confirmed coronavirus infections since the pandemic began crossed one million on Tuesday and hospitals in some hard-hit areas were near capacity.

Indonesia’s Health Ministry announced that new daily infections rose by 13,094 on Tuesday to bring the country’s total to 1,012,350, the most in Southeast Asia. The total number of deaths reached 28,468.

The milestone comes just weeks after Indonesia launched a massive campaign to inoculate two-thirds of the country’s 270 million people, with President Joko Widodo receiving the first shot of a Chinese-made vaccine. Health-care workers, military, police, teachers and other at-risk populations are being prioritized for the vaccine in the world’s fourth-most populous country.

Medical workers visit COVID-19 patients at a general hospital in Indonesia on Monday. (Adek Berry/AFP/Getty Images)

Chinese airlines are offering refunded tickets as the coronavirus continues to spread in the country’s northeast. The offer Tuesday from the government’s aviation authority comes amid a push to prevent people travelling during the Lunar New Year holiday next month.

In the Americas, Mexico’s death toll passed 150,000 on Monday following a surge in infections in recent weeks.

In Africa, Russia and China have approached Zimbabwe about supplying vaccines to tackle its escalating COVID-19 outbreak amid concern about Harare’s ability to afford the shots.

In the Middle East, Oman said earlier this week it will extend the closure of its land borders for another week until Feb. 1.

-From The Associated Press and Reuters, last updated at 7:10 a.m. ET

Let’s block ads! (Why?)



Source link

Continue Reading

Trending